HARROW, INC. — Director's Dealing 2012

Apr 28, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2011-12-12

Reporting Person: DERMASTAR INTERNATIONAL, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8240045	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$0.0017	2012-02-28	Common Stock (7498500)		Direct
Warrants	$1.185	2015-04-29	Common Stock (241308)		Direct

Footnotes

F1: DermaStar International, LLC ("DermaStar") is the direct beneficial owner of 8,240,045 shares of the Issuer's common stock. Mr. Mark L. Baum and Mr. Robert Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power over the 8,240,045 shares of common stock owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.

F2: DermaStar is the direct beneficial owner of 10 shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Preferred"). The Series A Preferred are convertible into a total of 7,498,500 shares of Common Stock. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the 7,498,500 shares of Common Stock underlying the Series A Preferred owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.

F3: DermaStar is the direct beneficial owner of warrants to purchase up to 241,308 shares of the Issuer's Common Stock at an exercise price of $1.185 (the "Warrants"). The Warrants expire on the third anniversary of the issuance date. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the Warrants and 241,308 shares of Common Stock underlying the Warrants owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.